StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$54.99−3.20 (-5.50%)

Close on Nov 16, 2026Market cap $7.16BP/E –Yield –

10x Genomics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

10x Genomics's profit margin for the twelve months ending Sep 30, 2026 was -10.8%. For fiscal 2025 it was -6.8%, against -29.9% the year before. The highest annual figure on record is -6.8% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-6.8%+23.1
FY2024Dec 31, 2024-29.9%+11.3
FY2023Dec 31, 2023-41.2%−9.1
FY2022Dec 31, 2022-32.1%−20.3
FY2021Dec 31, 2021-11.9%+169.7
FY2020Dec 31, 2020-181.6%−168.9
FY2019Dec 31, 2019-12.7%+64.2
FY2018Dec 31, 2018-76.9%−50.5
FY2017Dec 31, 2017-26.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-12.9%+5.5
Q2 FY2026Jun 30, 2026-11.9%−31.8
Q1 FY2026Mar 31, 2026-8.9%+13.3
Q4 FY2025Dec 31, 2025-9.8%+19.9
Q3 FY2025Sep 30, 2025-18.4%+5.1
Q2 FY2025Jun 30, 202520.0%+44.7
Q1 FY2025Mar 31, 2025-22.2%+20.3
Q4 FY2024Dec 31, 2024-29.7%−3.1
Q3 FY2024Sep 30, 2024-23.6%+36.9
Q2 FY2024Jun 30, 2024-24.8%+17.8
Q1 FY2024Mar 31, 2024-42.5%−4.7
Q4 FY2023Dec 31, 2023-26.6%−15.6
Q3 FY2023Sep 30, 2023-60.5%−28.5
Q2 FY2023Jun 30, 2023-42.5%+13.7
Q1 FY2023Mar 31, 2023-37.8%−0.7
Q4 FY2022Dec 31, 2022-11.0%+1.8
Q3 FY2022Sep 30, 2022-32.0%−18.3
Q2 FY2022Jun 30, 2022-56.2%−46.7
Q1 FY2022Mar 31, 2022-37.0%−26.1
Q4 FY2021Dec 31, 2021-12.9%+357.5
Q3 FY2021Sep 30, 2021-13.7%+78.0
Q2 FY2021Jun 30, 2021-9.5%+84.1
Q1 FY2021Mar 31, 2021-10.9%+18.5
Q4 FY2020Dec 31, 2020-370.3%−360.9
Q3 FY2020Sep 30, 2020-91.7%−76.0
Q2 FY2020Jun 30, 2020-93.6%−74.1
Q1 FY2020Mar 31, 2020-29.4%−22.6
Q4 FY2019Dec 31, 2019-9.5%+139.9
Q3 FY2019Sep 30, 2019-15.7%+26.2
Q2 FY2019Jun 30, 2019-19.5%−0.8
Q1 FY2019Mar 31, 2019-6.8%+50.5
Q4 FY2018Dec 31, 2018-149.4%–
Q3 FY2018Sep 30, 2018-41.9%–
Q2 FY2018Jun 30, 2018-18.7%–
Q1 FY2018Mar 31, 2018-57.3%–

More 10x Genomics figures

See a number that looks wrong?